Clinical trial
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung…
NCT00119613 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00119613 |
|---|---|
| Title | A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa |
| Official title | A Randomized, Double Blind, Placebo-Controlled Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | placebo, darbepoetin alfa |
| Enrollment | 600 |
| Start date | Dec 1, 2002 |
| Primary completion | Jan 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Jul 14, 2005 |
| Last update posted | Aug 8, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: